Clinical Trial Update: HER2-PET Imaging in HER2-low Breast Cancers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is investigating HER2-PET imaging for patients with HER2-low metastatic breast cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Breast Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING